The Bright Lifecare spinout, which counts Intel Capital as an investor, has now raised $37m in total, after securing $15m in a round led by HBM Healthcare.

The round, which was co-led by Pfizer, will support clinical trials of Complexa's kidney disease and pulmonary arterial hypertension treatments.

London School of Hygiene and Tropical Medicine has signed a deal with LifeArc for the charity to provide a range of technology transfer services to the institution.

Spun out of Boston University by Allied Minds in December last year, Signature Medical has secured $2.5m in series A funding from investors including Bose.

Rodeo Therapeutics has developed therapies to regenerate tissue, based on research undertaken at Case Western Reserve University and University of Texas Southwestern Medical Center.